chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient experienced nausea shortly after receiving the vaccine which lead to vomiting.  The patient stated she was nervous about getting the vaccine and felt better immediately after.
After receiving vaccine, patient began to feel nauseated and lighthead. BS was checked-normal, BP was checked-Low, Pulse-Elevated. Began to vomit. RRT and paramedics were called for further evaluation.
Fever 100.3. Chills exhaustion red circle at injection site itchy and hard
Patient ID: MRN:  Name:  Age: 71 y.o. Admit Date: 8/11/2022  4:24 PM Discharge Date: 8/16/2022 Unit:  Admitting Physician:  Discharge Physician: M.D.   Discharge Diagnosis: Principal Problem:   Obstructive jaundice Active Problems:   Bradycardia   Pneumonia due to COVID-19 virus   HTN (hypertension)   Chronic kidney disease, stage II (mild)       HPI: "Patient is a 71 y.o. male with a history of recurrent DVT's, is on eliquis. Patient had labs done per PCP and LFT's were up thus sent to ED. Timing of this uncertain as no sx. Nothing noted to make this better or worse. No present associated sx, no fever, no abdominal pain, no nausea. "   Hospital Course:  The patient was admitted to the hospital and was evaluated and treated per below.      * Obstructive jaundice o Obstructive Jaundice. S/P ERCP and lap chole this morning. A stone was extracted during ERCP. Swollen GB with stone in the cystic duct was found during surgery. Will continue monitor liver function with daily labs. WBC's trending up initially then down. Remains free of abdominal pain, fever or any other symptoms of infection. Procal trended down. Transitioned IV Zosyn to PO Augmentin. Follow up outpatient.  o Pneumonia due to COVID-19 virus. Remains asymptomatic from respiratory stand point.  Not on any treatment for COVID. Continue to monitor.  o Bradycardia. Improved and remains asymptomatic. Continue to monitor on telemetry.  o Hypertension. Controlled. Continue same treatment. Follow up daily labs.  o CKD stage 2. Remains at baseline. Monitor with daily labs.        Physical Exam on the Date of Discharge: Stable and improved      Consults:   IP CONSULT TO GASTROENTEROLOGY IP CONSULT TO GENERAL SURGERY IP CONSULT TO SOCIAL WORK IP CONSULT TO SOCIAL WORK IP CONSULT TO CARDIOLOGY IP CONSULT TO CARDIOLOGY   Significant Diagnostic Studies:    labs, microbiology, radiology, and cardiac graphics: per chart.     Disposition:  home   Discharge Condition:  good
Admitted from Hospital - symptomatic with cough, fever, fatigue,  and diarrhea
01/27/22 presents to ED for "body aches and dysuria". PMHx of " HTN, DM type 2, CVA"
Patient was complaining of eye issue on Thursday 01/21 and new medication was ordered.  Received vaccine Friday 01/22 and had no other complaints other than facial twitching.   Primary MD was contacted and patient was transferred to hospital for evaluation due to facial dropping.
Swelling in left arm 3" area of induration given Medrol Dose Pak.
Right arm swelling and redness - hive like at shoulder only. Fever, nausea.
Pt received the Pfizer covid vaccine at 02:20pm. Immediately after she began to feel numbness and tightness in her neck, throat, and mouth. The left side of her face felt numb, right side felt tight. she refused the EpiPen because she thought her anxiety was causing these feelings/reaction. Paramedics were called just in case, they checked her and she was told to go home and monitor herself. She stated she no longer felt numb at 02:37pm.
I never associated my side effects to this vaccine. I thought I was over worked or just sick from something else. I woke very stiff with joint pain, shoulder, wrist, neck, hip, traveling through my legs and ankle. I thought I had the flu again. The pain increased into my hands and wrists. Everything felt swollen. The pain would come and go. I also thought I was over worked again. I had acne pretty bad but thought that was my age issue.
Symptoms  Fever 100.4 chills, cough, Fatigue swelling at injection site severe fatigue and severe Malaise
REDNESS ( 2 X 3 INCH AREA )WARM TO TOUCH-NOT PAINFUL.
This case was reported by a physician via call center representative and described the occurrence of swelling arm in a 80-year-old female patient who received SHINGRIX for prophylaxis. On an unknown date, the patient received the 2nd dose of SHINGRIX. On an unknown date, less than a week after receiving SHINGRIX, the patient experienced swelling arm, pimples, nasal crusting, axillary lymph nodes enlarged and angular cheilitis. On an unknown date, the outcome of the swelling arm, pimples, nasal crusting and angular cheilitis were unknown and the outcome of the axillary lymph nodes enlarged was recovered/resolved. It was not reported if the reporter considered the swelling arm, pimples, nasal crusting, axillary lymph nodes enlarged and angular cheilitis to be related to SHINGRIX. Additional details were provided as follows: This case was reported via webform email. The patient received SHINGRIX on arm and her arm became swollen, not at the injection site; she had a swollen axillary lymph node. Three days after vaccination, the patient had sores at the corners of her mouth, bloody crusts in her nostrils, and a pimple on her nose. The caller did not speak with the HCP. This case has been linked to the US2018115892, reported by the same reporter for the same patient.
earache; headache; nausea; fever; chills; This case was reported by a consumer via call center representative and described the occurrence of ear pain in a 62-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 21st December 2021 09:40, the patient received the 1st dose of Shingrix. In December 2021, 18 hrs 50 min after receiving Shingrix, the patient experienced ear pain, headache, nausea, fever and chills. On an unknown date, the outcome of the ear pain, headache, nausea, fever and chills were not recovered/not resolved.   It was unknown if the reporter considered the ear pain, headache, nausea, fever and chills to be related to Shingrix.  Additional details were reported as follows: The case was reported by the patient. The patient had her Shingrix and next morning on 22nd December 2021 at 4.30 she started to experience, chills, fever, nausea, earache and a headache.  The reporter was given medical disclaimer, referred to health care professional (HCP), Spoke per (product insert) PI and content. The reporter consented to follow up.
25 mins after vaccination, patient began expressing throat tightness (10:23). Epinephrine 0.4 mg IM given at 10:25AM. EMS called at 10:25. 10:26AM O2 98% BP 160/90  (with BP cuff that was too tight). 10:28AM 15mg Zyrtec given PO.  Repeat NP at 10:35 with correct size BP cuff was 125/61. 97% O2 10:35 EMS arrived. Patients symptoms resolved shortly after administration of epi. No other symptoms developed other than throat tightness.
INJECTION SITE HARD LARGE NODULE, PAIN ERYTHEMA. EDEMA AT SITE PROGRESSED FROM DATE OF INJECTION. UNTIL ANTIBIOTIC REGIMEN STARTED 2 DAYS POST INJECTION WITH RAPID RECOVERY
Covid test result Positive; This is a spontaneous report from a contactable other health care professional (Patient). A 39 year old male customer (patient) reported that he received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot : El1283), via an unspecified route of administration, administered in Arm Left on 20Jan2021 (at the age of 38-year-old)13:15 as dose 1, single for COVID-19 immunization . Patient medical history included Shrimp allergy and COVID-19 from an unknown date and unknown if ongoing. The patient's concomitant medications were not reported. On 25Jan2021the patient experienced covid test result positive. The patient underwent lab tests and procedures which included sars-cov-2 test: positive on 25Jan2021 nasal swab (sample) and on 17Aug2021 sars-cov-2 test: negative nasal swab (sample). Outcome of the event Covid-19 was unknown.  Follow-up attempts are completed. No further information is expected
Felt rough/felt under the weather for the next two/three days; May have had the cold; Flu; A little sneeze; A virus the day he got the shot; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (Felt rough/felt under the weather for the next two/three days), NASOPHARYNGITIS (May have had the cold), INFLUENZA (Flu), SNEEZING (A little sneeze) and VIRAL INFECTION (A virus the day he got the shot) in a 77-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 044A21A and 013A21A) for COVID-19 vaccination.     The medical history information was not provided by the reporter.  Concomitant products included IBUPROFEN (ADVIL [IBUPROFEN]) for an unknown indication.   On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 26-Mar-2021, the patient experienced FEELING ABNORMAL (Felt rough/felt under the weather for the next two/three days), NASOPHARYNGITIS (May have had the cold), INFLUENZA (Flu), SNEEZING (A little sneeze) and VIRAL INFECTION (A virus the day he got the shot). At the time of the report, FEELING ABNORMAL (Felt rough/felt under the weather for the next two/three days), NASOPHARYNGITIS (May have had the cold), INFLUENZA (Flu), SNEEZING (A little sneeze) and VIRAL INFECTION (A virus the day he got the shot) outcome was unknown.            Concomitant medications also include antibiotics since 26-Mar-2021 for an unknown indication. Treatment information was not provided.  Patient did not have side effects with the first dose.
101 fever, rt arm swollen, red from shoulder to elbow within 8 hours....of recieving shot.  12/15 swelling went down into wrist area.  temperature gone still red/swollen. Called VNA-TIP on 12/14 left message this director was told that she took tylenol and contacted physician.  He was heading out of town she called us to inform of situation.  I advised her to apply ice to the area take tylenol and to let me know how things are overnight. She called me back mid morning said her pharmacist looked at her arm and suggested she go to the emergency room...I asked this patient to let me know how things go.
Mild injection site soreness; This is a spontaneous report from a contactable consumer (patient). A 69-year-old male (same age at vaccination) patient received first dose of bnt162b2 (BNT162B2, Solution for injection, Lot no: 59267-1000-01) via unspecified route of administration on 05Mar2021 11:30 AM in right arm for COVID-19 immunisation. other vaccine was also reported on 05Mar2021. Medical history was not reported. Concomitant medications reported was Hydrochlorothiazide 25mg and vitamins nos (MULTIVITAMIN). No COVID prior vaccination, neither patient COVID tested post vaccination and no known allergies were reported. Patient experienced Mild injection site soreness on 05Mar2021 at 03:00 PM. No treatment was received in response to the event. outcome of the event was recovered on an unspecified date.   No follow-up attempts are possible. No further information is expected.
Systemic: Chills-Medium, Systemic: Dizziness / Lightheadness-Medium, Systemic: Fainting / Unresponsive-Medium, Systemic: Flushed / Sweating-Medium, Systemic: Hypotension-Mild, Systemic: Visual Changes/Disturbances-Medium, Systemic: Weakness-Mild
I received the vaccine at 9:00am on Wednesday. By 5:00pm I had a severe fever, chills, fatigue, muscle aches and pains including my joints feeling like they were on fire, and the worst headache of my life. Today, Friday, I have no voice as it's made my voice very hoarse.
Area around injection site, raised and vesicular looking, arm became swollen and had extension of redness and swelling the length of the arm by day 2.
pt recv vax & exp diff in swallowing 6 days p/vax;pt was adm to hosp & so far the causes of the sx has not yet been identified, however GBS has been excluded;
Mother called on 5/17/02 stating son has large reddened area approx. 5" on left upper arm. No reaction previously. Instructed to apply ice X 20 minutes 4 to 5 X a day. To go to ER if area becomes larger. Mother verbalized understanding.
Unknown at this time; This case was reported by a lawyer and described the occurrence of adverse event in a patient who received Herpes zoster (Shingrix) (batch number unk, expiry date unknown) for prophylaxis.   On 24th December 2020, the patient received Shingrix (intramuscular). On an unknown date, an unknown time after receiving Shingrix, the patient experienced adverse event. The action taken with Shingrix was unknown. On an unknown date, the outcome of the adverse event was unknown.   It was unknown if the reporter considered the adverse event to be related to Shingrix.  Additional details: The patient ingested Shingrix vial on 24 December 2020. The patient had experienced event as Unknown at this time.
I was dealing with a kidney stone which started in late August. I ended up having that removed on 11/21/22. On 12/1/22 I had an issue with Atrial Fibrillation my heart rate had started going up it was in the high 90-106, the average was about 105 or 106. My diastolic blood pressure rate dropped at this point. I reached out to my cardiologist because I had an ablation before for the heart issue. They took a look at the information that my loop recorder had gathered and then they followed up with me after reviewing what was occurring with my heart. We did another ablation to correct this after we did lab work and talked about the option of mediation or another ablation. I have my follow up for that ablation that took place at the end of the December on the 24th of January. I had a flu shot on the same day that I got my COVID-19 booster but do not have the information for that shot.
The patient stated that her arm is slightly swollen and can not lift. Also stated that pain is radiating up to neck and down the arm.
Within 5 minutes of receiving all 4 vaccinations c/o feeling dizzy and blurry vision. Laid flat, skin warm and dry. After 5 minutes blurriness resolved. Sat up BP 116/82. Provided with Coke. Continued to c/o blurry vision better when lying flat. Rested 1 hour, continued to c/o blurry vision. Medical director recommended evaluatioin. Mother transported instructred to go to ER.
Acute mild throat tightness and lightheadedness that spontaneously resolved within 10 minutes. Given prescription for OTC Benadryl 25mg take one every 8 hours as needed.
Redness swelling, removal of bandages caused abrasion to adhesive side ,soaness tenderness and heat.
Pt reports post-vaccination facial flushing and scalp itching. Denies any shortness of breath, chest pain or itchiness in throat. Requests benadryl if available.   - Pt given 25mg PO benadryl, symptoms improved.
a rash on her face/ rash under eyes; blotchy rash; red rash/ red blanching; red eyes/ eyes were beet red; Pinkeye; fatigue; stayed in bed; didn't feel well; started retching; vomiting; headache; fever of 100 Fahrenheit temperature; This non-serious case was reported by a consumer via call center representative and described the occurrence of feeling unwell in a 75-year-old female patient who received RSVPreF3 adjuvanted (Arexvy) for prophylaxis.   On 09-OCT-2023, the patient received Arexvy (right arm). On 10-OCT-2023, 1 days after receiving Arexvy, the patient experienced exanthema facial (Verbatim: a rash on her face/ rash under eyes), blotchy rash (Verbatim: blotchy rash), red rash (Verbatim: red rash/ red blanching), eye red (Verbatim: red eyes/ eyes were beet red), pinkeye (Verbatim: Pinkeye), fatigue (Verbatim: fatigue) and bedridden (Verbatim: stayed in bed). In OCT-2023, the patient experienced feeling unwell (Verbatim: didn't feel well), retching (Verbatim: started retching), vomiting (Verbatim: vomiting), headache (Verbatim: headache) and fever (Verbatim: fever of 100 Fahrenheit temperature).  The outcome of the feeling unwell, retching, blotchy rash and bedridden were not reported and the outcome of the vomiting, headache, fever, red rash, eye red, pinkeye and fatigue were unknown and the outcome of the exanthema facial was not resolved.   It was unknown if the reporter considered the feeling unwell, retching, vomiting, headache, fever, exanthema facial, blotchy rash, red rash, eye red, pinkeye, fatigue and bedridden to be related to Arexvy.     It was unknown if the company considered the feeling unwell, retching, vomiting, headache, fever, exanthema facial, blotchy rash, red rash, eye red, pinkeye, fatigue and bedridden to be related to Arexvy.   Additional Information: GSK receipt date: 11-OCT-2023 Reporter was the patient, who received a dose of Arexvy on Monday. She stated that during that night did not felt well. The patient started retching and started to vomit, then experienced a severe headache in bed that night with fever of 100 degree Fahrenheit temperature.  The next morning, a rash was all over face that was blotchy and red with red blanching , eyes were beet red like pink eye.  Then on Tuesday, had fatigue the entire day and stayed in bed.  Out of everything no pain in the arm that was injected. The patient mentioned still have leftover rash on right side of face under eyes.  The reporter consented to follow up from safety
On or around 11/27 started with headache, scratchy throat, developed cough  On 11/2 went to urgent care due to severity of cough and congestion. I could not clear chest or breath easily. Was diagnosed with pneumonia
The patient was given the vaccine on 8/9/22 @ 1513 and then again (same lot and arm) on 8/10/22 @ 1142 accidentally.
Pt said he felt extremely hot, sweaty, and dizzy. He then fainted, falling and hitting the side of his face.
Pt to ED 8/11 for running nose, cough, sore throat and body aches for the past 2 days. COVID+ 8/11, discharged 8/11. Pt back to ED 8/15 for intermittent abdominal pain, nausea and diarrhea. Pt A&OX4. Resp even and unlabored, complaints of abdominal soreness. On room air,no acute resp distress. Pt discharged 8/16.
The day after I received the vaccine I had all the usual symptoms except throwing up.  What I want to report is this last week I had a re-occurring bout, but this time it was much worse and lasted for two days.  I had 100.5 fever, could not stand up without passing out and threw up.  In addition my blood pressure was dropping.  I was concerned about it happening again as I had not heard this was possible.  Am doing fine now.
DIAHRHEA; This is a spontaneous report from a contactable 71-year-old male consumer reported for himself that he received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/lot number: GL9267), via an unspecified route of administration on 17Feb2021 at 13:15 as single dose in left arm for covid-19 immunization. The patient relevant medical history was not reported. Historical vaccine included bnt162b2 for covid-19 immunization on 21Jan2021 (lot number-EL9263, Administration time=14:30, vaccine location -Right arm, dose number-1). Concomitant medications included Pantoprazole. On 18Feb2021 at 07:00, the patient experienced diahrhea. The patient did not take any treatment for the event. The outcome of the event was not recovered.
Diarrhea tingling & numbness to injection site and left leg, chills, off and on abdominal pain
Adacel vaccine, indicated for ages 10-64, was chosen for patient when inputted. Patient is over the age of 64 and would be indicated for Boostrix vaccine, which is indicated for 10+. Error was not caught before administration. Patient received Adacel vaccine.
pt began to exp malaise and vomiting 26APR;no BM since 26APR AM, progressively listless, vomiting all fluids,1 small black streaky stool;abd firmer & firmer, cried in pain, waxy, ill, listless in appearance;dx intussusception w/ resolution;
about 2min p/vax pt felt dizzy & turned pale & then collapsed, one jerking of body & lost consciousness lasting a few seconds (10 sec);numbness on face & tightness of stomach;
Approximately 8 hours after injections, onset of mild flu like symptoms - body aches, headache, burning eyes, fatigue; approximately 14 hours after injections, onset of fever of approx. 101; fever broke approx. 24 hours after injections, but body aches, fatigue persist; We are submitting this form because both patient and myself (spouse) experienced the most extreme side effects from getting both the Seasonal Flu and SHINGRIX vaccines at the same time (in years past, we have never gotten any sort of reaction from the Seasonal Flu vaccine).
Child received 2 vaccines in same arm/area. Area was darker in color, firm to touch, warm and tender to touch. Child stated he could not straighten/bend elbow. Mother stated she noticed swelling about 24 hours after. Child stated he had fallen on elbow at school.
Condition aggravated; Inflammation; This spontaneous case was reported by a consumer and describes the occurrence of CONDITION AGGRAVATED (Condition aggravated) and INFLAMMATION (Inflammation) in an adult female patient who received mRNA-1273 (Spikevax) for COVID-19 vaccination.    Co-suspect product included non-company product ADALIMUMAB (HUMIRA) for Crohn's disease and Psoriatic arthritis.    No Medical History information was reported.   On an unknown date, the patient received dose of mRNA-1273 (Spikevax) (Intramuscular) 1 dosage form and ADALIMUMAB (HUMIRA) (Subcutaneous) Citrate Free. On an unknown date, the patient experienced CONDITION AGGRAVATED (Condition aggravated) and INFLAMMATION (Inflammation). At the time of the report, CONDITION AGGRAVATED (Condition aggravated) and INFLAMMATION (Inflammation) outcome was unknown.        The action taken with mRNA-1273 (Spikevax) (Intramuscular) was unknown.       No concomitant drugs taken.  On unknown dates, the patient experienced body was not responding to humira/humira was not working, flares and inflammation. Moderna covid-19 vaccine (elasomeran) was also considered suspect.  It was unknown if patient was enrolled in a covid-19 vaccine trial.  Patient had no known allergies.  No treatment information was reported by the reporter.  This case was identified as part of a retrospective clean-up activity where certain emails received in the Moderna mailbox were missed to be booked-in.   Most recent FOLLOW-UP information incorporated above includes: On 25-Mar-2022: Significant follow up appended. Outcome of event drug ineffective was updated, Event verbatim updated, Action taken and de-challenge for co-suspect updated, Narrative updated
This case was reported by a pharmacist and described the occurrence of the use of expired vaccine in a subject of unspecified age and gender who was vaccinated with BOOSTRIX, GlaxoSmithKline.  On 24 July 2008 the subject received unspecified dose of BOOSTRIX (unknown).  After vaccination with BOOSTRIX, it was noted that the vaccine given to the subject had expired.  The pharmacist considered the event was clinically significant (or requiring intervention) only for the reason that the subject would have to receive another dose of vaccine.  No adverse events were reported.
constant ringing in both ears. began shortly after shot and has not stopped or weakened since. have never had this issue before
Severe bilateral arm pain, fatigue, fever, chills.  Onset 12/24/2020 10:00am until 2:00am.  Ibuprofen.  Person recovered.
This report described arthralgia in a vaccinee of unspecified age and gender who received Lyme disease vacicne recombinant. Allergies, medical history, and concomitant medications were not specified. On unspecified dates, the vaccinee recieved an unspecified number of doses of LYMErix. Six months after receiving vaccines, the patient reportedly complained of arthralgia. As of 6/13/01, the outcome of the event was unknown. The adverse event arthralgia does not meet ICH serious criteria, but is being submitted as an expedited report by special FDA request per the 6/28/00 letter. Additional information has been requested.